PKNOX1 and metabolic dysfunction-associated steatotic liver disease: Then we performed in vitro experiments to determine whether miR‐17‐mediated regulation of Pknox1 affects insulin signaling, similar to in vivo results in the T2DM/NAFLD rat model.